Gerard Berry

Gerard Berry is a Professor of Pediatrics at Harvard Medical School and an Attending Physician in the Division of Genetics and Genomics. He specializes in metabolic and genetic disorders, focusing on conditions like galactosemia, congenital disorders of glycosylation (CDG), and urea cycle disorders. He leads the Galactosemia Network (GalNet), a global registry for patients with galactosemia, and has contributed to international clinical guidelines for managing genetic metabolic diseases.

Education:

• Bachelor's degree in Pre-Med from the University of Notre Dame (1971)
• M.D. from Jefferson Medical College (1975)
• Pediatrics residency at Thomas Jefferson University Hospital (1978)
• Fellowships in Biochemical Genetics and Pediatric Endocrinology at Children's Hospital of Philadelphia (1981)

Research Interests: His work centers on understanding and improving treatments for inherited metabolic disorders, including galactosemia, PMM2-CDG, and urea cycle disorders. He investigates long-term complications (e.g., neurodevelopmental outcomes, reproductive health), dietary interventions, and novel therapies like triheptanoin for fatty acid oxidation disorders. He emphasizes translational research, linking molecular mechanisms to clinical care.

Publications: Dr. Berry's recent work highlights advancements in galactosemia treatment (e.g., liver transplantation outcomes), CDG natural history studies, and metabolic pathway analysis. His articles often address clinical management strategies and the impact of genetic mutations on disease severity.

Affiliations:

• Director of the Division of Genetics and Genomics at Boston Children's Hospital
• Member of the GalNet steering committee
• Principal investigator in NIH-funded studies on metabolic disorders

Labs/Teams: He leads a multidisciplinary team focused on metabolic genetics, collaborating with clinicians, geneticists, and biochemists to advance diagnostics and therapies for rare diseases.